Extramedullary plasmacytoma of the ureter.

extramedullary plasmacytoma hydronephrosis tumor ureter urothelial carcinoma

Journal

IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 26 07 2021
accepted: 30 08 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 11 1 2022
Statut: epublish

Résumé

We report a rare case of an extramedullary plasmacytoma of the ureter. A 77-year-old man was referred to our hospital because of left hydronephrosis. Computed tomography showed a tumor in the left ureter, and tumor invasion into the periureteric fat was suspected. Urine cytology showed Eatypical cells whose nuclei were hyperchromatic (class IIIb). The left ureteral tumor was diagnosed as urothelial carcinoma (cT3N0M0) preoperatively. Subsequently, we performed laparoscopic radical nephroureterectomy with bladder cuff excision. The tumor was pathologically diagnosed as a plasmacytoma. Postoperative positron emission tomography did not reveal abnormal uptake, and bone marrow aspiration findings were normal. Consequently, the left ureter tumor was diagnosed as an extramedullary plasmacytoma of the ureter. Extramedullary plasmacytoma commonly occurs in the upper respiratory tract or upper gastrointestinal tract. Extramedullary plasmacytoma of the ureter is rare. This is only the fourth reported case of extramedullary plasmacytoma of the ureter.

Identifiants

pubmed: 35005462
doi: 10.1002/iju5.12373
pii: IJU512373
pmc: PMC8720724
doi:

Types de publication

Case Reports

Langues

eng

Pagination

19-22

Informations de copyright

© 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Am J Hematol. 2008 Sep;83(9):702-7
pubmed: 18543343
BJU Int. 2017 Sep;120(3):313-319
pubmed: 28621055
Arab J Urol. 2021 Feb 16;19(1):46-58
pubmed: 33763248
J Urol. 1999 Mar;161(3):783-5
pubmed: 10022684
Br J Haematol. 2003 Jun;121(5):749-57
pubmed: 12780789
Medicine (Baltimore). 2018 Nov;97(46):e13177
pubmed: 30431591
BMC Urol. 2018 Aug 31;18(1):73
pubmed: 30170590
BJU Int. 2018 Feb;121(2):184-193
pubmed: 29032580
Aktuelle Urol. 2009 May;40(3):175-8
pubmed: 19370534
Urol Int. 2010;84(1):122-4
pubmed: 20173384
Postgrad Med. 2020 Sep;132(7):657-661
pubmed: 32348167
Blood. 2003 Mar 1;101(5):1715-7
pubmed: 12393501
Int J Radiat Oncol Biol Phys. 1980 Nov;6(11):1497-501
pubmed: 6780494
BMJ Case Rep. 2017 Apr 7;2017:
pubmed: 28389594
Br J Cancer. 1997;75(6):921-7
pubmed: 9062417
Cancer. 1999 Jun 1;85(11):2305-14
pubmed: 10357398
ScientificWorldJournal. 2012;2012:895765
pubmed: 22654647
Pathol Res Pract. 2020 Feb;216(2):152788
pubmed: 31859117
Clin Exp Metastasis. 2019 Dec;36(6):499-509
pubmed: 31446521
Int Cancer Conf J. 2017 May 27;6(4):171-174
pubmed: 31149496
Clin Oncol (R Coll Radiol). 2004 Sep;16(6):405-13
pubmed: 15487132

Auteurs

Shuhei Okada (S)

Department of Urology Mito Medical Center Higashiibaraki-gun Ibaraki-ken Japan.

Yasushi Ichimura (Y)

Department of Urology Mito Medical Center Higashiibaraki-gun Ibaraki-ken Japan.

Masahiro Iinuma (M)

Department of Urology Mito Medical Center Higashiibaraki-gun Ibaraki-ken Japan.

Classifications MeSH